Synthesis and evaluation of brain-targeted chemical delivery systems for the neurotrophomodulator 4-methylcatechol

Journal of Pharmacy and Pharmacology

Volumn 49, Issue 1, 1997, Pages 1-9

  Kourounakis, Angeliki ^a   Bodor, Nicholas ^a   Simpkins, James ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUFFER; DIHYDROPYRIDINE; GUAIACOL; MESSENGER RNA; NERVE GROWTH FACTOR; PYRIDINIUM DERIVATIVE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOT HYBRIDIZATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG STABILITY; DRUG SYNTHESIS; DRUG TARGETING; FRONTAL CORTEX; HIPPOCAMPUS; INTRAVENOUS DRUG ADMINISTRATION; MALE; NERVE DEGENERATION; NONHUMAN; OXIDATION REDUCTION REACTION; RAT;

EID: 0031027656     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1997.tb06742.x     Document Type: Article

References (22)

1. Bakhit, C., Armanini, M., Bennett, G. L., Wong, W. L. T., Hansen, S. E., Taylor, R. (1991) Increase in glia-derived NGF following destruction of hippocampal neurons. Brain Res. 56: 76-83
2. Bodor, N., Brewster, M. (1983) Problems of delivery of drugs to the brain. Pharm. Ther. 19: 337-386
3. Bodor, N.; Farag, H. (1983) Improved delivery through biological membranes. 13. Brain specific delivery of dopamine with a dihydropyridine/pyridinium salt type redox delivery system. J. Med. Chem. 2: 528-534
4. Brewster, M., Robledo-Luiggi, C., Miyake, A., Pop, E., Bodor, N. (1989) Improved delivery through biological membranes. 44. Brain-enhanced delivery of anti-dementia drugs. In: Meyer, E., Simpkins, J., Yamamoto, J. (eds) Novel Approaches to the Treatment of Alzheimer's Disease. Plenum, N.Y., pp 173-183
5. Carswell, S. (1993) The potential for treating neurodegenerative disorders with NGF-inducing compounds. Exp. Neurol. 124: 36-42
6. Carswell, S., Hoffman, E. K., Clopton-Hartpence, K., Wilcox, H. M., Lewis, M. E. (1992) Induction of NGF by isoproterenol, 4-methyl-catechol and serum occurs by three distinct mechanisms. Mol. Brain Res. 15: 145-150
7. Chomczynski, P., Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159
8. De Bernardi, M. A., Fabrazzo, M., Mocchetti, I. (1991) Transcriptional regulation of nerve growth factor gene. In: Costa, E., Joh, T. (eds) Neurotransmitter Regulation of Gene Transcription. Thieme, N.Y., pp 37-46
9. Follesa, P., Mocchetti, I. (1992) Regulation of basic fibroblast growth factor and nerve growth factor mRNA by β-adrenergic receptor activation and adrenal steroids in rat central nervous system. Mol. Pharmacol. 43: 132-138
10. Furukawa, Y., Tomioka, N., Satoyoushi, E., Hayashi, K., Furukawa, S. (1989) Catecholamines increase nerve growth factor mRNA content in both mouse astroglial cells and fibroblast cells. FEBS Lett. 247: 463-467
11. Furukawa, Y., Fukazawa, N., Miyama, Y., Hayashi, K., Furukawa, S. (1991) Stimulatory effect of 4-alkylcatechols and their diacetylated derivatives on the synthesis of nerve growth factor. Biochem. Pharmacol. 40: 2337-2342
12. Hanaoka, Y., Ohi, T., Furukawa, S., Furukawa, Y., Hayashi, K., Matwukura, S. (1994) The therapeutic effects of 4-methylcatechol, a stimulator of endogenous nerve growth factor synthesis, on experimental diabetic neuropathy in rats. J. Neurol. Sci. 122: 28-32
13. Kaechi, K., Furukawa, Y., Idegami, R., Nakamura, N., Omae, F., Hashimoto, Y., Hayashi, K., Furukawa, S. (1993) Pharmacological induction of physiologically active nerve growth factor in rat peripheral nervous system. J. Pharmacol. Exp. Ther. 264: 321-326
14. Lapchak, P. A. (1993) Nerve growth factor pharmacology: application to the treatment of cholinergic neurodegeneration in Alzheimer's disease. Exp. Neurol. 124: 16-20
15. Mocchetti, I. (1991) Theoretical basis for a pharmacology of nerve growth factor biosynthesis. Ann. Rev. Pharmacol. Toxicol. 32: 303-328
16. Olson, L. (1993) NGF and the treatment of Alzheimer's diseases. Exp. Neurol. 124: 5-15
17. Sambrook, J., Fritsch, E. F., Maniatis, T. (1989) Molecular Cloning: a Laboratory Manual. Cold Spring Harbor, N.Y.
18. Saporito, M. S., Wilcox, H. M., Hartpence, K. C., Lewis, M. E., Vaught, J. L., Carswell, S. (1993) Pharmacological induction of nerve growth factor mRNA in adult rat brain. Exp. Neurol. 123: 295-302
19. Schwartz, J.P. (1988) Stimulation of nerve growth factor mRNA content in C6 glioma cells by a β-adrenergic receptor and by cyclic AMP. Glia 1: 282-285
20. Thoenen, H., Zafra, F., Hengerer, B., Lindholm, D. (1991) The synthesis of nerve growth factor and brain-derived neurotrophic factor in hippocampal and cortical neurons is regulated by specific transmitter systems. Ann. NY Acad. Sci. 12: 86-90
21. Whittemore, S. R., Seiger, A. (1987) The expression, localization and functional significancer of β-nerve growth factor in the central nervous system. Brain Res. Rev. 12: 439-464
22. Whittemore, S. R., Friedman, P. L., Larhammar, D., Persoon, H., Gonzalez-Carvajal, M., Holets, V. R. (1988) Rat β-nerve growth factor sequence and site of synthesis in the adult hippocampus. J. Neurosci. Res. 20: 403-410